Medicine & Life Sciences
Visceral Leishmaniasis
100%
Parasites
97%
Cutaneous Leishmaniasis
92%
Leishmania donovani
88%
Leishmaniasis
82%
Leishmania
61%
Cricetinae
57%
Cytokines
54%
Infections
48%
Recombinases
44%
Malnutrition
36%
Macrophages
32%
Interleukin-12
32%
Interleukin-10
29%
Skin
26%
Interleukin-4
25%
Leishmania major
25%
Dendritic Cells
24%
T-Lymphocytes
23%
Spleen
21%
Leishmania mexicana
20%
Antigens
19%
Lymph Nodes
18%
Point-of-Care Systems
18%
Mesocricetus
18%
CCR2 Receptors
17%
Messenger RNA
16%
Vaccines
16%
Psychodidae
16%
Infection Control
14%
Cardiomyopathies
14%
Animals
14%
Nitric Oxide
13%
Complementary DNA
13%
Arginase
13%
Polymerase Chain Reaction
13%
Sigmodontinae
13%
Asymptomatic Infections
12%
Canidae
12%
DNA
12%
Cellular Immunity
12%
Dogs
12%
Nitric Oxide Synthase
11%
Chagas Disease
11%
Inflammation
11%
Lipopolysaccharides
11%
SARS Virus
11%
Tumor Necrosis Factor-alpha
11%
Parasite Load
10%
Neutrophils
10%
Agriculture & Biology
visceral leishmaniasis
50%
Leishmania donovani
43%
parasites
29%
infection
25%
cytokines
21%
hamsters
18%
Leishmania
18%
interleukin-4
16%
interleukin-10
15%
macrophages
15%
lesions (animal)
14%
T-lymphocytes
14%
cutaneous leishmaniasis
13%
leishmaniasis
12%
interleukin-12
12%
cell-mediated immunity
11%
arginase
11%
dogs
11%
lymph nodes
11%
recombinant vaccines
11%
antigens
10%
immune response
10%
malnutrition
10%
recombinases
8%
vaccines
8%
Leishmania mexicana
8%
Protozoa
7%
splenocytes
6%
dendritic cells
6%
spleen
6%
inflammation
6%
Neotoma floridana
6%
Leishmania amazonensis
6%
neurocysticercosis
6%
promastigotes
6%
phenotype
6%
Oryzomys
6%
mice
5%
Phlebotominae
5%
Mesocricetus auratus
5%
cohort studies
5%
animal models
5%